Coronavirus

1737 bookmarks
Newest
Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials
Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials
Asymptomatic or minimally symptomatic infection with COVID-19 can result in silent transmission to large numbers of individuals, resulting in expansion of the pandemic with a global increase in morbidity and mortality. New ways of screening the general ...
·ncbi.nlm.nih.gov·
Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials
Institutionalized Medical Malpractice & COVID
Institutionalized Medical Malpractice & COVID
It’s been over six weeks since Iowa dropped all state-level COVID restrictions, and surprise, surprise, hospitalized patients are down 54 percent. But if you try to Google this information, all you will see is death, dying, and it must be the end of the world because of COVID, which miraculously seems to be a cure... View Article
·drsircus.com·
Institutionalized Medical Malpractice & COVID
Ivermectin Dose For COVID (Prophylaxis, Acute Disease, Long Haulers) - YouTube
Ivermectin Dose For COVID (Prophylaxis, Acute Disease, Long Haulers) - YouTube
In this talk, we will discuss the possible dose of Ivermectin for prophylaxis, during the acute disease, and for the long haulers. We will look at the dosage used by various studies, myself for my patients, and recommended by the physicians at FLCCC.net. Note: this is not a prescription. This material is for the educational purpose only.
·youtube.com·
Ivermectin Dose For COVID (Prophylaxis, Acute Disease, Long Haulers) - YouTube
Ivermectin Works For COVID-19 - LATEST STUDIES - YouTube
Ivermectin Works For COVID-19 - LATEST STUDIES - YouTube
Ivermectin Works For COVID-19 - LATEST STUDIES More lectures on drbeen.com Looking to support my educational work? Donate here: https://paypal.me/mobeensyed?locale.x=en_US Start your free trial - no credit card needed: https://members.drbeen.com/freetrial Original in-vitro study about Ivermectin https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129059/ A study from bangladesh found that Ivermectin + Doxyclyclin significantly reduces mortality and morbidity in COVID-19 patients. https://clinicaltrials.gov/ct2/show/study/NCT04523831 A systemic review of the antiviral activity of Ivermectin https://www.nature.com/articles/s41429-020-0336-z https://journal.chestnet.org/article/S0012-3692(20)34898-4/fulltext PDF for the above study after it was accepted https://journal.chestnet.org/article/S0012-3692(20)34898-4/pdf Pre-print of the above study https://www.medrxiv.org/content/10.1101/2020.06.06.20124461v2 A search of various Ivermectin studies for your reading pleasure https://clinicaltrials.gov/ct2/results?cond=Covid19&term=ivermectin&cntry=&state=&city=&dist= Iota carrageenan and Ivermectin oral drops https://clinicaltrials.gov/ct2/show/results/NCT04425850?term=ivermectin&cond=Covid19&draw=2
·youtube.com·
Ivermectin Works For COVID-19 - LATEST STUDIES - YouTube
Microvascular dysfunction in COVID-19 the MYSTIC study SpringerLink
Microvascular dysfunction in COVID-19 the MYSTIC study SpringerLink
Rationale Pre-clinical and autopsy studies have fueled the hypothesis that a dysregulated vascular endothelium might play a central role in the pathogenesis of ARDS and multi-organ failure in COVID-19. Objectives To comprehensively characterize and quantify microvascular alterations in patients with COVID-19. Methods Hospitalized adult patients with moderate-to-severe or critical COVID-19 (n = 23) were enrolled non-consecutively in this prospective, observational, cross-sectional, multi-center study. Fifteen healthy volunteers served as controls. All participants underwent intravital microscopy by sidestream dark field imaging to quantify vascular density, red blood cell velocity (VRBC), and glycocalyx dimensions (perfused boundary region, PBR) in sublingual microvessels. Circulating levels of endothelial and glycocalyx-associated markers were measured by multiplex proximity extension assay and enzyme-linked immunosorbent assay. Measurements and main results COVID-19 patients showed an up to 90% reduction in vascular density, almost exclusively limited to small capillaries (diameter 4–6 µm), and also significant reductions of VRBC. Especially, patients on mechanical ventilation showed severe glycocalyx damage as indicated by higher PBR values (i.e., thinner glycocalyx) and increased blood levels of shed glycocalyx constituents. Several markers of endothelial dysfunction were increased and correlated with disease severity in COVID-19. PBR (AUC 0.75, p = 0.01), ADAMTS13 (von Willebrand factor-cleaving protease; AUC 0.74, p = 0.02), and vascular endothelial growth factor A (VEGF-A; AUC 0.73, p = 0.04) showed the best discriminatory ability to predict 60-day in-hospital mortality. Conclusions Our data clearly show severe alterations of the microcirculation and the endothelial glycocalyx in patients with COVID-19. Future therapeutic approaches should consider the importance of systemic vascular involvement in COVID-19.
·link.springer.com·
Microvascular dysfunction in COVID-19 the MYSTIC study SpringerLink
Nebulizing Magnesium and other Medicinals
Nebulizing Magnesium and other Medicinals
Nebulizing Magnesium and other natural medicinals as Iodine, Sodium Bicarbonate, peroxide and glutathione are strong treatment options that deliver the medicinals directly to the tracheobronchial tree.
·drsircus.com·
Nebulizing Magnesium and other Medicinals